XML 42 R32.htm IDEA: XBRL DOCUMENT
v3.22.2

Business Combinations (Tables) | 9 Months Ended
--- | ---
Jun. 25, 2022
Business Combinations [Abstract] |
Schedule of Recognized Identified Assets Acquired and Liabilities Assumed | The total purchase price was allocated to Bolder's preliminary tangible and identifiable intangible assets and liabilities based on the estimated fair values as of November 29, 2021, as set forth below.
Cash |  | $ | 1.9 |
Accounts receivable | 1.3 |
Inventory | 3.3 |
Other assets | 3.0 |
Accounts payable and accrued expenses | (3.2) |
Identifiable intangible assets: |
| Developed technology | 73.6 |
| Customer relationship | 21.7 |
| Trade names | 1.4 |
Deferred income taxes, net | (13.8) |
Goodwill | 70.9 |
Purchase Price | $ | 160.1 |
The total purchase price was allocated to Mobidiag's tangible and identifiable intangible assets and liabilities based on the estimated fair values as of June 17, 2021, as set forth below.
Cash |  | $ | 7.0 |
Accounts receivable | 4.2 |
Inventory | 12.1 |
Other assets | 29.6 |
Accounts payable and accrued expenses | (16.5) |
Other liabilities | (12.2) |
Identifiable intangible assets: |
| Developed technology | 285.0 |
| In-process research and development | 74.0 |
| Customer relationships | 20.9 |
| Trade names | 20.0 |
Long-term debt | (66.1) |
Deferred income taxes, net | (56.1) |
Goodwill | 427.7 |
Purchase Price | $ | 729.6 |
The total purchase price was allocated to Biotheranostics' tangible and identifiable intangible assets and liabilities based on the estimated fair values as of February 22, 2021, as set forth below.
Cash |  | $ | 9.6 |
Accounts receivable | 6.6 |
Other assets | 6.5 |
Accounts payable and accrued expenses | (8.2) |
Other liabilities | (8.1) |
Identifiable intangible assets: |
| Developed technology | 160.3 |
| Trade names | 2.1 |
Deferred income taxes, net | (18.4) |
Goodwill | 80.9 |
Purchase Price | $ | 231.3 |
The total purchase price was allocated to Diagenode's tangible and identifiable intangible assets and liabilities based on the estimated fair values as of March 1, 2021, as set forth below.
Cash |  | $ | 5.6 |
Accounts receivable | 9.3 |
Inventory | 9.0 |
Other assets | 13.9 |
Accounts payable and accrued expenses | (16.7) |
Other liabilities | (9.2) |
Identifiable intangible assets: |
| Developed technology | 69.8 |
| Customer relationships | 9.2 |
Deferred income taxes, net | (19.3) |
Goodwill | 83.5 |
Purchase Price | $ | 155.1 |

X
- References No definition available. + Details
Name: | us-gaap_BusinessCombinationsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the amounts recognized as of the acquisition date for each major class of assets acquired and liabilities assumed. May include but not limited to the following: (a) acquired receivables; (b) contingencies recognized at the acquisition date; and (c) the fair value of noncontrolling interests in the acquiree. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 805 -SubTopic 20 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=123413009&loc=d3e4845-128472 + Details
Name: | us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration